Search clinical trials for: Shock-induced endotheliopathy

Total 7 results

Pär Johansson
Odense University Hospital; Oslo University Hospital; Aarhus University Hospital and other collaborators

Completed

Infusion of Prostacyclin vs Placebo for 72-hours in Trauma Patients With Haemorrhagic Shock Suffering From Organ Failure (SHINE-TRAUMA)

Multi Organ Failure

Denmark, Norway
Hospices Civils de Lyon

Not yet recruiting

Platelet Activation in Delayed Cerebral Ischemia Secondary to Aneurysmal Subarachnoid Hemorrhage (APICRASH)

Delayed Cerebral Ischemia | Endotheliopathy | Aneuvrysmal Subarachnoid Hemorrhage | Platelets Kinetic

France
Pär Johansson

Recruiting

Infusion of Prostacyclin vs Placebo for 72-hours in Mechanically Ventilated Patients With Acute Respiratory Failure (COMBAT-ARF)

Endothelial Dysfunction | Acute Respiratory Failure | Pulmonary Infection

Denmark
Medical University of Lublin

Recruiting

Xanthohumol as an Adjuvant in the Treatment of Septic Shock

Pneumonia | Septic Shock | ARDS

Poland
St. Jude Children's Research Hospital
Baylor College of Medicine; University of Tennessee; Le Bonheur Children's Hospital

Recruiting

Early Detection of Endotheliopathy Post-Transplant

Endotheliopathy

United States
Pär Johansson

Completed

Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure (COMBAT-COVID)

COVID-19 | Respiratory Failure

Denmark
Ohio State University
Genzyme, a Sanofi Company

Completed

Establishment of Biomarkers for Fabry Disease

Fabry Disease

United States

3

Subscribe